ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Synovitis"

  • Abstract Number: 0800 • ACR Convergence 2021

    Digital Spatial Profiling Reveals Distinct Synovial Tissue Transcriptomic Signature of Sustained Disease Remission in Rheumatoid Arthritis Patients at Risk of Disease Flare After Treatment Tapering or Discontinuation

    Stefano Alivernini1, Simone Perniola2, Marco Gessi3, Maria Rita Gigante4, Clara Di Mario5, Luca Petricca4, Dario Bruno5, Laura Bui1, Annamaria Paglionico1, Valentina Varriano1, Maria Antonietta D'Agostino6, Barbara Tolusso1 and Elisa Gremese7, 1Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy, 2Fondazione Policlinico Universitario A. Gemelli IRCCS - University of Verona, Santeramo in Colle, Italy, 3Fondazione PoliclinicoUniversitario A. Gemelli IRCCS, Rome, Italy, 4Division of Rheumatology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy, 5Division of Rheumatology, Università Cattolica del Sacro Cuore, Rome, Italy, 6Fondazione Policlinico Universitario A. Gemelli IRCCS - Università Cattolica del Sacro Cuore, Rome, Italy, 7Division of Rheumatology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy

    Background/Purpose: Sustained disease remission is the treatment goal for Rheumatoid Arthritis (RA) leading patients to be eligible to treatment tapering or discontinuation. However, disease flare…
  • Abstract Number: 0943 • ACR Convergence 2021

    Metabolomic Profiling of Synovial Tissue of Patients with Osteoarthritis

    Jessica Murillo Saich1, Roxana Coras2, Robert Meyer3 and Monica Guma4, 1University of California San Diego, La Jolla, CA, 2University of California San Diego/Department of Medicine, Autonomous University of Barcelona, San Diego, CA, 3San Diego VA Healthcare Service, La Jolla, CA, 4University of California San Diego/San Diego VA Healthcare Service/Department of Medicine, Autonomous University of Barcelona, La Jolla, CA

    Background/Purpose: Increasing evidence indicates that osteoarthritis (OA) progression is mediated not simply by progressive degeneration of cartilage, but also by low-grade synovial inflammation (synovitis) that…
  • Abstract Number: 0945 • ACR Convergence 2021

    A Single-cell Atlas of Human Synovial Endothelial Cells in Inflammatory Arthritis

    Sam Edalat1, Reto Gerber2, Miranda Houtman1, Raphael Micheroli3, Kristina Buerki1, Nadja Izanc1, Blaz Burja4, Tadeja Kuret5, Snežna Sodin-Šemrl5, Adrian Ciurea3, Oliver Distler3, Caroline Ospelt1, Chantal Pauli6, Mark Robinson7 and Mojca Frank-Bertoncelj3, 1Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland, 2Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich and Department of Molecular Life Sciences and SIB Swiss Institute of Bioinformatics, University of Zurich, Zurich, Switzerland, 3Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich/University of Zurich, Zurich, Switzerland, 4Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich and Department of Rheumatology, University Medical Centre Ljubljana, Zurich, Switzerland, 5Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia, 6Department of Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland, 7Department of Molecular Life Sciences and SIB Swiss Institute of Bioinformatics, University of Zurich, Zurich, Switzerland

    Background/Purpose: Dysregulated endothelial cell (EC) function and altered (lympho)angiogenesis crucially contribute to synovial pathology in inflammatory arthritis. Additionally, endothelium plays a key role in the…
  • Abstract Number: 0968 • ACR Convergence 2021

    Granzyme K+ CD8 T Cells Form the Core Population of Inflamed Human Tissue-associated CD8 T Cells

    Anna Helena Jonsson1, Fan Zhang2, Emma Gomez-Rivas1, Gerald Watts1, Garett Dunlap3, Heather Faust1, Karishma Rupani1, Joseph Mears1, Deepak Rao1, Runci Wang4, Gregory Keras1, Nida Meednu5, Jonathan Coblyn1, Elena Massarotti1, Derrick Todd1, Andrew McDavid6, Jennifer Anolik5, Accelerating Medicines Partnership AMP: RA/SLE Network7, Kevin Wei1, Soumya Raychaudhuri1 and Michael Brenner8, 1Brigham and Women's Hospital, Boston, MA, 2Harvard Medical School, Boston, MA, 3Harvard University, Somerville, MA, 4Brigham and Women’s Hospital, Boston, MA, 5University of Rochester Medical center, Rochester, NY, 6University of Rochester, Rochester, NY, 7NIH/FNIH, Bethesda, MD, 8Brigham and Women's Hospital, Harvard Medical School, Newton, MA

    Background/Purpose: T cell-derived pro-inflammatory cytokines are a major driver of rheumatoid arthritis (RA) pathogenesis. While CD4 T cells have traditionally been assumed to be the…
  • Abstract Number: 1125 • ACR Convergence 2021

    Synovial Perivascular Edema Is Associated with Altered Knee Loading Patterns During Gait in Patients with Medial Compartment-Dominant Knee Osteoarthritis

    McKenzie Carter1, Holly Philpott1, Trevor Birmingham2, Ryan Pinto3, Codie Primeau1, J. Robert Giffin1, Brent Lanting2 and Tom Appleton2, 1Western University, London, ON, Canada, 2University of Western Ontario, London, ON, Canada, 3Western University, Kitchener, ON, Canada

    Background/Purpose: Synovial inflammation and aberrant joint loads are independent risk factors for knee osteoarthritis (OA) incidence and progression. Perivascular edema, the accumulation of fluid around…
  • Abstract Number: 1221 • ACR Convergence 2021

    Association of Neutrophil Lymphocyte and Platelet Lymphocyte Ratios with Joint Inflammation in Rheumatoid Arthritis

    Diyu Pearce-Fisher1, Dana Orange2, Bella Mehta3, Deanna Jannat-Khah1 and Susan Goodman1, 1Hospital for Special Surgery, New York, NY, 2The Rockefeller University, New York, NY, 3Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

    Background/Purpose: It can be challenging to determine whether rheumatoid arthritis (RA) patients who require arthroplasty have ongoing inflammation, in addition to damage in the affected…
  • Abstract Number: 1358 • ACR Convergence 2021

    Clusters of Psoriatic Arthritis Patients at Baseline Based on Different Ultrasound Detected Synovitis: Exploratory Analysis from a Phase III Study

    Maria Antonietta D'Agostino1, Georg Schett2, Corine Gaillez3, Philip Conaghan4, Esperanza Naredo5, Philippe Carron6, Ruben Burgos-Vargas7, Peter Mandl8, Javier Rosa9, Maarten Boers10, Punit Goyanka11, Weibin Bao12 and David Demanse3, 1Rheumatology, Fondazione Policlinico Universitario “Gemelli”, IRCCS, Rome, Italy, 2Universitätsklinikum Erlangen, Department of Internal Medicine 3 – Rheumatology and Immunology, Erlangen, Germany, Erlangen, Germany, 3Novartis Pharma AG, Basel, Switzerland, 4Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 5Department of Rheumatology and Joint and Bone Research Unit, Hospital Fundación Jiménez Díaz and Autónoma University, Madrid, Spain, 6Department of Rheumatology, University Hospital Ghent, University of Ghent, Ghent, Belgium, 7Department of Rheumatology, General Hospital of Mexico, Ciudad de Mxico, Mexico, 8Medical University of Vienna, Vienna, Austria, 9Rheumatology Unit, Internal Medical Services, and University Institute, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 10Amsterdam UMC, Vrije Universiteit, Amsterdam, Netherlands, 11Novartis Healthcare Pvt Ltd, Hyderabad, India, Hyderabad, India, 12Novartis, East Hanover, NJ

    Background/Purpose: Psoriatic arthritis (PsA) is characterized by inflammation of synovial membranes and entheseal sites leading to pain, structural damage, impairment of physical function and quality…
  • Abstract Number: 0793 • ACR Convergence 2020

    Topological Laser Capture Microscopy (LCM)-RNAseq to Map the Rheumatoid Arthritis (RA) Synovial Transcriptome

    Benjamin Van Espen1, Andrew Wilson1, Gregory Seumois2, Narayanan Perumal3, Robert Benschop4, Gary Firestein5, Nunzio Bottini5 and Stephanie Stanford1, 1University of California, San Diego, La Jolla, 2La Jolla Institute for Immunology, La Jolla, 3Eli Lilly, Indianapolis, 4Eli Lilly and Company, Indianapolis, IN, 5University of California, San Diego, La Jolla, CA

    Background/Purpose: Understanding pathogenic processes in the diseased tissue in rheumatoid arthritis (RA) is a critical step to defining disease pathogenesis and identifying novel therapeutic targets.…
  • Abstract Number: 2047 • ACR Convergence 2020

    Synovial CD8 T Cells in Rheumatoid Arthritis Exhibit High Antigen-independent Cytokine Production and Low Cytotoxic Potential

    Anna Helena Jonsson1, Fan Zhang2, Emma Gomez-Rivas3, Karishma Rupani4, Gerald Watts5, Kevin Wei1, Runci Wang4, Deepak Rao4, Accelerating Medicines Partnership (AMP) - RA/SLE6, Soumya Raychaudhuri2 and Michael Brenner1, 1Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 2Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, 3Division of Rheumatology, Brigham and Women's Hospital, Boston, MA, 4Brigham and Women's Hospital, Boston, MA, 5Brigam and Women's Hospital, Boston, 6., Boston

    Background/Purpose: T cell-derived pro-inflammatory cytokines are major drivers of RA pathogenesis, and these cytokines have traditionally been attributed to CD4 T cells.  However, single-cell RNA-sequencing…
  • Abstract Number: 0796 • ACR Convergence 2020

    Development of a Tool to Assess Synovial Tissue Infiltrates and Derive Histological Pathotype in Inflammatory Arthritis: Relationship to Clinical and Ultrasound Variables

    Hayley Carr1, Ilfita Sahbudin1, Mark Maybury1, Bernard Dyke2, Jason Turner3, Nicola Gullick4, Karim Raza5, Dagmar Scheel-Toellner1 and Andrew Filer1, 1Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom, 2Institute of Inflammation and Ageing, University of Birmingham, Birmingham, England, United Kingdom, 3Rheumatology Research Group, Institute for Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Queen Elizabeth Hospital, Birmingham, United Kingdom, 4University Hospitals Coventry & Warwickshire, Coventry, United Kingdom, 5Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, United Kingdom

    Background/Purpose: Evidence suggests that histological pathotypes are linked to pathogenic mechanisms in inflammatory arthritis and may be useful as biomarkers of outcome. The frequently used…
  • Abstract Number: 0940 • ACR Convergence 2020

    In Patients with Inflammatory Arthritides Central Pain Sensitization Is Strictly Associated with Functional Disability

    Giovanni Adami1, Angelo Fassio1, Elisabetta Gerratana2, Alessandro Giollo1, Camilla Benini1, Luca Idolazzi1, Elisabetta Vantaggiato1, Davide Gatti1 and Maurizio Rossini1, 1Rheumatology Unit, University of Verona, Verona, Italy, 2Rheumatology Unit, University of Messina, Messina, Italy

    Background/Purpose: Long-term nociceptive pain, as in inflammatory arthritides, can cause Central Sensitization (CS) to pain. CS Inventory (CSI) is a validated screening instrument for clinicians to…
  • Abstract Number: 0968 • ACR Convergence 2020

    Combined Inhibition of Autophagy and Glutamine Metabolism Suppresses Cell Growth of RA Synoviocytes and Ameliorates Arthritis in SKG Mice

    Ikuko Naka1, Jun Saegusa2, Kenichi Uto2, Yuzuru Yamamoto3, Yoshihide Ichise4, Hirotaka Yamada4, Yo Ueda5, Takaichi Okano4, Soshi Takahashi6, Sho Sendo7 and Akio Morinobu8, 1Kobe University, Kobe, 2Department of Clinical Laboratory, Kobe University Hospital, Kobe, Japan, 3Kobe University, Kobe-city, Japan, 4Kobe University, Kobe, Japan, 5Kobe UniversityRheumatology and Clinical Immunology, Kobe University Hospital, Kobe, Japan, 6Kobe univerity, Kobe, Japan, 7Kobe university, Kobe city, Japan, 8Rheumatology and Clinical Immunology, Kobe University Hospital, Kobe, Japan

    Background/Purpose: Immunometabolism is now recognaized to be crucial in the pathogenesis of rheumatoid arthritis (RA). We have recently shown that the expression of glutaminase 1…
  • Abstract Number: 0973 • ACR Convergence 2020

    Novel Network Tool Highlights Key Features Associated with Disease Pathotypes and Response to Treatment in Early Rheumatoid Arthritis

    Elisabetta Sciacca1, Anna Surace2, Myles Lewis1, Salvatore Alaimo3, Vito Latora4, Felice Rivellese1, Alfredo Pulvirenti3, Alfredo Ferro3 and Costantino Pitzalis5, 1Centre for Experimental Medicine and Rheumatology, Queen Mary University of London, London, United Kingdom, 2Centre for Experimental Medicine and Rheumatology, Queen Mary University of London, Liverpool, United Kingdom, 3Bioinformatics Unit, Dept of Clinical and Experimental Medicine, University of Catania, Catania, Sicilia, Italy, 4School of Mathematical Sciences Queen Mary, University of London, London, United Kingdom, 5Queen Mary University of London, London, United Kingdom

    Background/Purpose: Biomedical research uses many statistical/bioinformatics tools to find genes or proteins differentially expressed between patient group of interest. However, biological elements are related to…
  • Abstract Number: 1078 • ACR Convergence 2020

    Highly Reactive anti-Jo1 Autoantibodies to Distinct HisRS Variants and Domains Associate with Lung and Joint Involvement in Patients with Myositis

    Antonella Notarnicola1, Charlotta Preger2, Susanna L. Lundström2, Nuria Renard2, Edvard Wigren2, Eveline Van Gompel2, Angeles S. Galindo-Feria2, Helena Persson3, Maryam Fathi4, Johan Grunewald2, Per-Johan Jakobsson2, Susanne Gräslund2, Ingrid Lundberg5 and Cátia Fernandes-Cerqueira2, 1Karolinska Institutet, Stockholm, Stockholms Lan, Sweden, 2Karolinska Institutet, stockholm, Sweden, 3Science for Life Laboratories, KTH, Stockholm, Sweden, 4Karolinska University Hospital, stockholm, Sweden, 5Division of Rheumatology, Department of Medicine, Karolinska Institutet,, Stockholm, Sweden

    Background/Purpose: To address the reactivity and affinity against histidyl-transfer RNA synthetase (HisRS) autoantigen of anti-Jo1 autoantibodies from serum and bronchoalveolar lavage fluid (BALF) and associations…
  • Abstract Number: 1110 • ACR Convergence 2020

    Osteoarthritis-Related Knee Inflammation Measured by Ultrasound Is Associated with Performance-Based Measures of Function

    Holly Philpott1, Trevor Birmingham2, Ryan Pinto2, Dominique Arsenault2, Codie Primeau2, Edward Vasarhelyi3, Steven MacDonald3, Brent Lanting3 and Tom Appleton4, 1Western University, London, ON, Canada, 2Western University, London, Canada, 3London Health Sciences Centre, London, Canada, 4The University of Western Ontario, LONDON, ON, Canada

    Background/Purpose: Signs of inflammation in knee osteoarthritis (OA), including synovitis, are associated with worse clinical outcomes such as increased pain, risk of progression, and future…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology